Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways

Recent studies have implicated Toll-like receptor 2 (TLR2) and TLR4 signaling in delimiting liver and brain injury following ischemia-reperfusion (I/R). To determine whether TLR2 and TLR4 conferred cytoprotection in the heart, we subjected hearts of wild-type (WT) mice and mice deficient in TLR2 (TL...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology. Heart and circulatory physiology 2010-03, Vol.298 (3), p.H1079-H1087
Main Authors: Dong, Jian-Wen, Vallejo, Jesus G, Tzeng, Huei-Ping, Thomas, James A, Mann, Douglas L
Format: Article
Language:English
Subjects:
Animals
Brain damage
Disease Models, Animal
Glycogen Synthase Kinase 3 - metabolism
Glycogen Synthase Kinase 3 beta
Heart attacks
Immunity, Innate - physiology
Ischemia
Ischemic Preconditioning, Myocardial
Kinases
Lipopeptides - therapeutic use
Liver
Male
Membrane Glycoproteins - deficiency
Membrane Glycoproteins - physiology
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Myocardial Reperfusion Injury - complications
Myocardial Reperfusion Injury - physiopathology
Physiology
Protein Kinase C-epsilon - metabolism
Proteins
Receptors, Interleukin-1 - deficiency
Receptors, Interleukin-1 - physiology
Rodents
Signal Transduction - physiology
Toll-Like Receptor 2 - deficiency
Toll-Like Receptor 2 - physiology
Toll-Like Receptor 4 - deficiency
Toll-Like Receptor 4 - physiology
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - prevention & control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies have implicated Toll-like receptor 2 (TLR2) and TLR4 signaling in delimiting liver and brain injury following ischemia-reperfusion (I/R). To determine whether TLR2 and TLR4 conferred cytoprotection in the heart, we subjected hearts of wild-type (WT) mice and mice deficient in TLR2 (TLR2D), TLR4 (TLR4D), and TIR domain-containing adapter protein (TIRAP-D) to ischemic preconditioning (IPC). Langendorff-perfused hearts were subjected to 30 min ischemia and 60 min reperfusion with or without IPC. IPC resulted in a significant increase (P < 0.05) in the percent recovery of left ventricular developed pressure (%LVDP) in WT mouse hearts (54.4 +/- 2.7% of baseline), whereas there was no significant increase in %LVDP (P > 0.05) in TIRAP-D mouse hearts (43.8 +/- 1.9%) after I/R injury. IPC also resulted in a significant (P < 0.05) decrease in I/R-induced creatine kinase release and Evans blue dye uptake in WT but not TIRAP-D hearts. Interestingly, IPC resulted in a significant (P < 0.05) increase in %LVDP in TLR4-deficient hearts (52.7 +/- 3%) but not in TLR2D hearts (39.3 +/- 1.5%). Pretreatment with a specific TLR2 ligand (Pam3CSK) protected WT hearts against I/R-induced left ventricular dysfunction. The loss of IPC-induced cardioprotection in TIRAP-D mouse hearts was accompanied by a decreased translocation of protein kinase C-epsilon and decreased phosphorylation of GSK-3beta. Taken together, these data suggest that the cardioprotective effect of IPC is mediated, at least in part, through a TLR2-TIRAP-dependent pathway, suggesting that the modulation of this pathway represents a viable target for reducing I/R injury.
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00306.2009